{"transactions":[{"id":1852575,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52912,"kind":"person","name":"Fatal Sigal","position":1,"cik":"0001850994","reported_name":"Fatal Sigal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-06-16T20:03:05.000Z","date":"2021-11-11","kind":"grant","planned":false,"acquired":true,"shares":35600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable pursuant to the following schedule: 25% of the options vested on November 11, 2022, and the remainder shall vest over three years in quarterly equal installments, subject to acceleration upon a change in control pursuant (\"CIC\") and continued service by the Reporting Person. In addition, following a CIC, the exercise period of the option shall be extended to 12 months following termination of service, other than in the event of termination For Cause (as defined in the Plan)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":35600,"derivative":{"exercise_price":9.83,"expiration_date":"2031-11-11","underlying":"American Depositary Shares","underlying_shares":35600},"source":{"system":"sec-edgar","filing":"0001178913-23-002227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850994/000117891323002227/ownership.xml","form_type":"4"}},{"id":1852574,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52912,"kind":"person","name":"Fatal Sigal","position":1,"cik":"0001850994","reported_name":"Fatal Sigal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-06-16T20:03:05.000Z","date":"2022-11-08","kind":"grant","planned":false,"acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable pursuant to the following schedule: 25% of the options shall vest on November 8, 2023, and the remainder shall vest over three years in quarterly equal installments, subject to acceleration upon a change in control (\"CIC\") and continued service by the Reporting Person. In addition, following a CIC, the exercise period of the option shall be extended to 12 months following termination of service, other than in the event of termination For Cause (as defined in the Plan)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":65000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-11-08","underlying":"American Depositary Shares","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0001178913-23-002227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850994/000117891323002227/ownership.xml","form_type":"4"}},{"id":1852573,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52912,"kind":"person","name":"Fatal Sigal","position":1,"cik":"0001850994","reported_name":"Fatal Sigal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-06-16T20:03:05.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":102860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted under the Company's 2017 Equity-Based Incentive Plan (the \"Plan\") on June 14, 2023; 25% of the options vest and become exercisable following 12 months from the grant thereof and an additional 6.25% vests at the end of each calendar quarter thereafter such that the options are fully vested and exercisable on June 14, 2027, subject to acceleration upon a change in control pursuant to the terms of the Option Agreement (\"CIC\") by and between the Reporting Person and the Issuer and continued service by the Reporting Person. In addition, following a CIC, the exercise period of the option shall be extended to 12 months following termination of service, other than in the event of termination For Cause (as defined in the Plan)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":167860,"derivative":{"exercise_price":1.7,"expiration_date":"2033-06-14","underlying":"American Depositary Shares","underlying_shares":102860},"source":{"system":"sec-edgar","filing":"0001178913-23-002227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850994/000117891323002227/ownership.xml","form_type":"4"}},{"id":2721212,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52912,"kind":"person","name":"Fatal Sigal","position":1,"cik":"0001850994","reported_name":"Fatal Sigal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-05-10T20:01:22.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":35653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable pursuant to the following schedule: 25% of the options shall vest on the first anniversary of November 7, 2020, and the remainder shall vest over three years in quarterly equal installments, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":35653,"derivative":{"exercise_price":27.26,"expiration_date":"2031-05-07","underlying":"American Depositary Shares","underlying_shares":35653},"source":{"system":"sec-edgar","filing":"0001104659-21-063814","document":"tm2115776-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850994/000110465921063814/tm2115776-1_4seq1.xml","form_type":"4"}}]}